Literature DB >> 10065387

[Direct and indirect costs of schizophrenia].

W Kissling1, J Höffler, U Seemann, P Müller, E Rüther, U Trenckmann, A Uber, J M Graf von der Schulenburg, P Glaser, T Glaser, O Mast, D Schmidt.   

Abstract

In the present study the costs of schizophrenia in Germany were studied using the "bottom up" prevalence-based method. In a random sample of 180 schizophrenic patients stratified according to the most important care institutions, direct and indirect costs were retrospectively documented for a 12-month period. Depending on the place of recruitment and the extent of care provided, total yearly costs result between about DM 33,000 for a patient treated predominantly on an outpatient basis and about DM 126,000 for a patient requiring hospital care and about DM 135,000 for a patient in job rehabilitation. The direct yearly treatment costs were, as expected, lowest for patients recruited in the private practice of a psychiatrist and predominantly treated on an outpatient basis (DM 5,788), and were the highest in the psychiatric hospital (DM 64,661) and in job rehabilitation (DM 79,996). In the patients recruited in the outpatient domain, doctors' fees and medication together were responsible for only 4.5% of the total costs, whereas the indirect costs (e.g., through work incapacity) were responsible for 87% of the total yearly costs. For methodological reasons the total costs caused by schizophrenic psychoses in Germany per year can at present be estimated only roughly. A conservative estimate is between 8.5 and 18 billion DM per year. The study shows that schizophrenia is a very expensive illness, the direct and indirect costs of which are on the whole comparable to those of the common somatic illnesses. Therefore, also for economical reasons, sufficient financial means should be invested in the research and treatment of this severe illness.

Entities:  

Mesh:

Year:  1999        PMID: 10065387     DOI: 10.1055/s-2007-993735

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  14 in total

1.  Recent approaches to psychological interventions for people at risk of psychosis.

Authors:  Andreas Bechdolf; Lisa J Phillips; Shona M Francey; Steven Leicester; Anthony P Morrison; Verena Veith; Joachim Klosterkötter; Patrick D McGorry
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-04       Impact factor: 5.270

2.  [Psychiatry in transitions of the public health system].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

Review 3.  Mental health care in Germany: current state and trends.

Authors:  Hans Joachim Salize; Wulf Rössler; Thomas Becker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-03       Impact factor: 5.270

4.  [Guidelines based on decision support software. Quality management in neurological outpatient schizophrenia treatment].

Authors:  B Janssen; R Menke; F Pourhassan; D Gessner-Ozokyay; R Peters; W Gaebel
Journal:  Nervenarzt       Date:  2006-05       Impact factor: 1.214

5.  Effectiveness and costs of flupentixol compared to other first- and second-generation antipsychotics in the treatment of schizophrenia.

Authors:  Tom Stargardt; Paraskevi Mavrogiorgou; Christian A Gericke; Georg Juckel
Journal:  Psychopharmacology (Berl)       Date:  2011-03-25       Impact factor: 4.530

6.  [The impact of the study design and the sampling procedure on the assessment of mental health services].

Authors:  R Kilian; C Roick; M C Angermeyer
Journal:  Nervenarzt       Date:  2003-06-26       Impact factor: 1.214

7.  [Sociotherapy in German social law. Indication, contents, and aspects of public health].

Authors:  R-M Frieboes
Journal:  Nervenarzt       Date:  2003-06-13       Impact factor: 1.214

8.  Indicated prevention of schizophrenia.

Authors:  Joachim Klosterkötter
Journal:  Dtsch Arztebl Int       Date:  2008-07-25       Impact factor: 5.594

9.  Impact of socio-economic status in meeting the needs of people with mental illness; human rights perspective.

Authors:  Poreddi Vijayalakshmi; Konduru Reddemma; Suresh Bada Math
Journal:  Community Ment Health J       Date:  2013-01-04

10.  The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective.

Authors:  Jan Zeidler; Lara Slawik; Jochen Fleischmann; Wolfgang Greiner
Journal:  Health Econ Rev       Date:  2012-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.